All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
During the EHA2021 Virtual Congress, the AML Hub spoke with Olga Gavrilina, National Research Center for Hematology, Moscow, RU. We asked, How does COVID-19 affect outcomes in AML?
How does COVID-19 affect outcomes in AML?
In this video, Gavrilina evaluates treatment outcomes, risk factors, prognosis, and mortality rates related to patients with AML and SARS-CoV-2 infection in a real-world setting.
COVID-HEME forum supports hematologists during COVID-19 pandemic
COVID-HEME is a peer-to-peer forum for physicians about the care of patients with hematologic malignancies during the COVID-19 pandemic. The goal of this collaborative platform is to...
Fungal superinfections and COVID-19 in the ICU
The COVID-19 pandemic has caused a worldwide healthcare crisis. In addition to the morbidity caused by the initial infection, severely ill patients are also at increased risk of secondary infections....
Subscribe to get the best content related to AML delivered to your inbox